NCT04704947View on ClinicalTrials.gov

Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

PHASE3RecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

October 1, 2030

Study Completion Date

October 1, 2030

Conditions

Beta Blocker Toxicity

Interventions

DRUG

nonselective beta blocker

nonselective beta blocker

DRUG

cardio-selective beta blocker group

cardio-selective beta blocker group

DRUG

alendronate sodium

alendronate sodium

Trial Locations (1)

35127

RECRUITING

Sherief Abd-Elsalam, Tanta

All Listed Sponsors

lead

Sherief Abd-Elsalam

OTHER